132 related articles for article (PubMed ID: 10583079)
21. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream.
Devirgiliis V; Panasiti V; Curzio M; Gobbi S; Rossi M; Roberti V; Calvieri S
Dermatol Online J; 2008 Feb; 14(2):25. PubMed ID: 18700128
[No Abstract] [Full Text] [Related]
22. Problems associated with the use of broad-band illumination sources for photodynamic therapy.
Stringer MR
Phys Med Biol; 1995 Oct; 40(10):1733-5. PubMed ID: 8532752
[No Abstract] [Full Text] [Related]
23. Nevus sebaceus on the face: Experience with photodynamic therapy in adults and children.
Moreno-Arrones OM; Perez-Garcia B
Indian J Dermatol Venereol Leprol; 2019; 85(4):440. PubMed ID: 30073978
[No Abstract] [Full Text] [Related]
24. Optical coherence tomography imaging of basal cell carcinoma undergoing photodynamic therapy: A pilot study.
Niculescu L; Bierhoff E; Hartmann D; Ruzicka T; Berking C; Braunmühl TV
Photodiagnosis Photodyn Ther; 2017 Jun; 18():133-137. PubMed ID: 28179181
[No Abstract] [Full Text] [Related]
25. A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes.
Sebaratnam DF; Venugopal SS; Murrell DF
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):117-8. PubMed ID: 20456551
[No Abstract] [Full Text] [Related]
26. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
27. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
28. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
Szeimies RM
Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
[TBL] [Abstract][Full Text] [Related]
29. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
30. Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation.
Downs AM; Bower CB; Oliver DA; Stone CA
Br J Dermatol; 2009 Jul; 161(1):189-90. PubMed ID: 19416229
[No Abstract] [Full Text] [Related]
31. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
Wolfe CM; Green WH; Hatfield HK; Cognetta AB
J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
[TBL] [Abstract][Full Text] [Related]
32. Lesion compression during light activation may improve efficacy of photodynamic treatment of basal cell carcinoma: preliminary results and rationale.
Stephens R; Holmes J; Eadie E
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e628-e630. PubMed ID: 32311807
[No Abstract] [Full Text] [Related]
33. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion.
Hürlimann AF; Hänggi G; Panizzon RG
Dermatology; 1998; 197(3):248-54. PubMed ID: 9812030
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
Cosgarea R; Susan M; Crisan M; Senila S
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
[TBL] [Abstract][Full Text] [Related]
35. Topical photodynamic therapy in clinical dermatology.
Kormeili T; Yamauchi PS; Lowe NJ
Br J Dermatol; 2004 Jun; 150(6):1061-9. PubMed ID: 15214890
[TBL] [Abstract][Full Text] [Related]
36. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
[TBL] [Abstract][Full Text] [Related]
37. [Photodynamic therapy of nasal basal cell carcinoma].
Haddad R; Cohen M; Kaplan O; Greenberg R; Kashtan H
Harefuah; 2001 Jan; 140(1):25-7, 86. PubMed ID: 11242893
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic laser therapy of basal-cell carcinoma of the lid.
Hintschich C; Feyh J; Beyer-Machule C; Riedel K; Ludwig K
Ger J Ophthalmol; 1993 Aug; 2(4-5):212-7. PubMed ID: 8220101
[TBL] [Abstract][Full Text] [Related]
39. [Photodynamic therapy of a giant basal cell carcinoma in a 71-year-old woman].
Darr-Foit S; Elsner P; Goetze S
Hautarzt; 2020 May; 71(5):380-382. PubMed ID: 32144442
[No Abstract] [Full Text] [Related]
40. A safe and effective treatment: Surgery combined with photodynamic therapy for multiple basal cell carcinomas.
Cao D; Zhu W; Kuang Y; Zhao S
Photodiagnosis Photodyn Ther; 2019 Dec; 28():133-135. PubMed ID: 31521714
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
